Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.36 | 1.72 |
NAV | ₹203.53 | ₹185.06 |
Fund Started | 07 May 2007 | 15 Feb 2007 |
Fund Size | ₹89383.23 Cr | ₹10007.39 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.94% | 6.69% |
3 Year | 24.58% | 25.95% |
5 Year | 26.08% | 25.11% |
1 Year
3 Year
5 Year
Equity | 93.94% | 99.43% |
Cash | 6.06% | 0.57% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Assets |
|---|---|
AU Small Finance Bank Ltd. | 5.59% |
Swiggy Ltd. | 5.23% |
The Federal Bank Ltd. | 5.07% |
L&T Finance Ltd. | 4.89% |
Prestige Estates Projects Ltd. | 4.59% |
BSE Ltd. | 4.04% |
Max Financial Services Ltd. | 4.02% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Sai Life Sciences Ltd. | 3.30% |
JK Cement Ltd. | 3.19% |
Name | Chirag Setalvad | Amit Ganatra |
Start Date | 28 Jun 2014 | 03 Oct 2025 |
Name
Start Date
Description | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 07 May 2007 | 15 Feb 2007 |
Description
Launch Date